Many respiratory drugs are not available in formulations suitable for
infants and toddlers. Efficacy and safety research is mostly restricted to
older children. However, respiratory drugs are frequently used in children
for common diseases like asthma, upper and lower respiratory tract
infections, rhinitis and sinusitis. The unlicensed and off-label use of
respiratory drugs in children were studied. A population-based cohor